drugset / Trial / NCT03099005

Effect of Cannabis and Endocannabinoids on HIV Neuropathic Pain

NCT03099005

Phase 2 Completed 5 enrolled University of California, San Diego
RandomizedCrossoverQuadruple-blindTreatment

Summary

Acute cannabis administration is reported to alleviate HIV neuropathic pain (HIV-NP), but there is limited knowledge about the effects of cannabis constituents (delta-9 tetrahydrocannabinol/THC and cannabidiol/CBD), the consequences of long-term cannabis use, and the impact of cannabis on endocannabinoid (EC) function in people living with HIV- NP. Our objective is to address these three fundamental gaps in our knowledge by: 1) examining the acute effects of various CBD/THC products on HIV-NP, 2) utilizing a mHealth text messaging protocol, Individual Monitoring of Pain and Cannabis Taken (IMPACT) to monitor daily real-world cannabis use and changes in pain; and 3) studying the relationship between cannabinoids, EC biomarkers, and chronic neuropathic pain

Timeline

Start
2018-07-01
Primary completion
2022-12-31
Completion
2022-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cannabis Traditional medicine (herbal / TCM) 0.01 % Inhaled
Comparator Cannabis Traditional medicine (herbal / TCM) 0.49 % Inhaled
Comparator Cannabis Traditional medicine (herbal / TCM) 1.4 % Inhaled
Comparator Cannabis Traditional medicine (herbal / TCM) 1.9 % Inhaled
Comparator Cannabis Traditional medicine (herbal / TCM) 3.11 % Inhaled
Comparator Cannabis Traditional medicine (herbal / TCM) 3.49 % Inhaled
Comparator Cannabis Traditional medicine (herbal / TCM) 3.74 % Inhaled
Comparator Cannabis Traditional medicine (herbal / TCM) 4.17 % Inhaled
Comparator Cannabis Traditional medicine (herbal / TCM) 5.1 % Inhaled
Comparator Cannabis Traditional medicine (herbal / TCM) 15.76 % Inhaled